News
04-03-2015, 12:18 AM
Today, Thomas Jefferson University announces a partnership with Exosome Sciences Inc. to evaluate a novel liquid biopsy platform that might offer clinicians new and actionable information about a patient's cancer as the disease progresses and changes, via a simple blood test.
More... (http://www.news-medical.net/news/20150403/Thomas-Jefferson-University-Exosome-Sciences-team-up-to-evaluate-new-liquid-biopsy-platform.aspx)
More... (http://www.news-medical.net/news/20150403/Thomas-Jefferson-University-Exosome-Sciences-team-up-to-evaluate-new-liquid-biopsy-platform.aspx)